BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 15229480)

  • 1. Metabolic profiles of cancer cells.
    Griffin JL; Shockcor JP
    Nat Rev Cancer; 2004 Jul; 4(7):551-61. PubMed ID: 15229480
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour metabolomics in animal models of human cancer.
    Griffin JL; Kauppinen RA
    J Proteome Res; 2007 Feb; 6(2):498-505. PubMed ID: 17269706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
    Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
    Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells in solid tumors.
    Ailles LE; Weissman IL
    Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
    Winquist RJ; Boucher DM; Wood M; Furey BF
    Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From cancer metabolism to new biomarkers and drug targets.
    Chiaradonna F; Moresco RM; Airoldi C; Gaglio D; Palorini R; Nicotra F; Messa C; Alberghina L
    Biotechnol Adv; 2012; 30(1):30-51. PubMed ID: 21802503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mono-, di-, and tri-tert-butyl ethers of glycerol. A molecular spectroscopic study.
    Jamróz ME; Jarosz M; Witowska-Jarosz J; Bednarek E; Tecza W; Jamróz MH; Dobrowolski JC; Kijeński J
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Jul; 67(3-4):980-8. PubMed ID: 17085068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-renewal and solid tumor stem cells.
    Al-Hajj M; Clarke MF
    Oncogene; 2004 Sep; 23(43):7274-82. PubMed ID: 15378087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cell genomics: the quest for early markers of malignant progression.
    Okamoto OK
    Expert Rev Mol Diagn; 2009 Sep; 9(6):545-54. PubMed ID: 19732002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells in the crosshairs.
    Schmidt C
    Cancer Discov; 2012 May; 2(5):384. PubMed ID: 22588862
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy.
    Ellis DI; Goodacre R
    Analyst; 2006 Aug; 131(8):875-85. PubMed ID: 17028718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer stem cell].
    Sakashita H; Ieta K; Haraguchi N; Inoue Y; Yoshizawa Y; Mori M
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1721-9. PubMed ID: 18030004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells.
    Sandoval M; Harris L
    Oncology (Williston Park); 2014 Dec; 28(12):1110-1, 1114. PubMed ID: 25510810
    [No Abstract]   [Full Text] [Related]  

  • 18. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)].
    Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D
    J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer stem cells and molecular targeting medicine].
    Kondo T
    Nihon Rinsho; 2010 Jun; 68(6):986-9. PubMed ID: 20535945
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.